We recently sat down with Snowdome Board Director, Helen Buckingham OAM, to get her thoughts on the funding of a new immunotherapy treatment for myeloma, and how clinicians and patients can have their say. Please tell us a bit about yourself My name is Helen Buckingham and I have been involved with Snowdome as a Board Director since its inception in 2010. My background is in politics, and I have...




Snowdome in the news
-
-
A state of the art, purpose-built laboratory complex in Victoria will provide new hope to Australian blood cancer patients. Based in Richmond, Melbourne, the...
-
Snowdome is incredibly proud to continue our international collaboration with the Leukemia & Lymphoma Society in the USA and the Leukaemia Foundation to fund...